Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Fast-food meal reduces peripheral artery endothelial function but not cerebral vascular hypercapnic reactivity in healthy young men.

Patik JC, Tucker WJ, Curtis BM, Nelson MD, Nasirian A, Park S, Brothers RM.

Physiol Rep. 2018 Sep;6(18):e13867. doi: 10.14814/phy2.13867.

2.

Sex differences in the mechanisms mediating blunted cutaneous microvascular function in young black men and women.

Patik JC, Curtis BM, Nasirian A, Vranish JR, Fadel PJ, Brothers RM.

Am J Physiol Heart Circ Physiol. 2018 Oct 1;315(4):H1063-H1071. doi: 10.1152/ajpheart.00142.2018. Epub 2018 Aug 3.

PMID:
30074835
3.

Atypical Noncrescentic Antiglomerular Basement Membrane Disease With Concurrent Thin Basement Membrane Nephropathy.

Singhal P, Ren KYM, Curtis BM, MacPherson I, Avila-Casado C.

Kidney Int Rep. 2018 Mar 23;3(4):991-996. doi: 10.1016/j.ekir.2018.03.012. eCollection 2018 Jul. No abstract available.

4.

Costs Associated With Intravenous Darbepoetin Versus Epoetin Therapy in Hemodialysis Patients: A Randomized Controlled Trial.

Woodland AL, Murphy SW, Curtis BM, Barrett BJ.

Can J Kidney Health Dis. 2017 Jun 30;4:2054358117716461. doi: 10.1177/2054358117716461. eCollection 2017.

5.

Randomized controlled trials 1: Design.

Curtis BM, Barrett BJ, Parfrey PS.

Methods Mol Biol. 2015;1281:159-75. doi: 10.1007/978-1-4939-2428-8_9.

PMID:
25694309
6.

Slow and sustained nitric oxide releasing compounds inhibit multipotent vascular stem cell proliferation and differentiation without causing cell death.

Curtis BM, Leix KA, Ji Y, Glaves RS, Ash DE, Mohanty DK.

Biochem Biophys Res Commun. 2014 Jul 18;450(1):208-12. doi: 10.1016/j.bbrc.2014.05.087. Epub 2014 May 27.

7.

Cardiac biomarkers and health-related quality of life in new hemodialysis patients without symptomatic cardiac disease.

Williams CE, Curtis BM, Randell EW, Foley RN, Parfrey PS.

Can J Kidney Health Dis. 2014 Jul 15;1:16. doi: 10.1186/2054-3581-1-16. eCollection 2014.

8.

Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease.

Foley RN, Curtis BM, Randell EW, Parfrey PS.

Clin J Am Soc Nephrol. 2010 May;5(5):805-13. doi: 10.2215/CJN.07761109. Epub 2010 Apr 8.

9.

Erythropoietin therapy, hemoglobin targets, and quality of life in healthy hemodialysis patients: a randomized trial.

Foley RN, Curtis BM, Parfrey PS.

Clin J Am Soc Nephrol. 2009 Apr;4(4):726-33. doi: 10.2215/CJN.04950908. Epub 2009 Apr 1.

10.

The design of randomized controlled trials.

Curtis BM, Barrett BJ, Parfrey PS.

Methods Mol Biol. 2009;473:95-111. doi: 10.1007/978-1-59745-385-1_5. Review.

PMID:
19160733
11.

Hemoglobin targets and blood transfusions in hemodialysis patients without symptomatic cardiac disease receiving erythropoietin therapy.

Foley RN, Curtis BM, Parfrey PS.

Clin J Am Soc Nephrol. 2008 Nov;3(6):1669-75. doi: 10.2215/CJN.02100508. Epub 2008 Oct 15.

12.

Evaluation and treatment of CKD patients before and at their first nephrologist encounter in Canada.

Curtis BM, Barrett BJ, Djurdjev O, Singer J, Levin A.

Am J Kidney Dis. 2007 Nov;50(5):733-42.

PMID:
17954286
13.
14.

Multiple risk factor intervention in chronic kidney disease: management of cardiac disease in chronic kidney disease patients.

Curtis BM, Levin A, Parfrey PS.

Med Clin North Am. 2005 May;89(3):511-23. Review.

PMID:
15755465
15.

The short- and long-term impact of multi-disciplinary clinics in addition to standard nephrology care on patient outcomes.

Curtis BM, Ravani P, Malberti F, Kennett F, Taylor PA, Djurdjev O, Levin A.

Nephrol Dial Transplant. 2005 Jan;20(1):147-54. Epub 2004 Dec 7.

PMID:
15585514
16.

How to design a clinical trial.

Curtis BM, Barrett BJ, Parfrey PS.

Methods Mol Med. 2003;86:475-89. No abstract available.

PMID:
12886789
17.

Canadian survey of clinical status at dialysis initiation 1998-1999: a multicenter prospective survey.

Curtis BM, Barret BJ, Jindal K, Djurdjev O, Levin A, Barre P, Bernstein K, Blake P, Carlisle E, Cartier P, Clase C, Culleton B, Deziel C, Donnelly S, Ethier J, Fine A, Ganz G, Goldstein M, Kappel J, Karr G, Langlois S, Mendelssohn D, Muirhead N, Murphy B, Pylpchuk G, Toffelmire E; CREDA (Canadian Renal Disease Alliance).

Clin Nephrol. 2002 Oct;58(4):282-8.

PMID:
12400843
18.

Understanding the Mediterranean diet. Could this be the new "gold standard" for heart disease prevention?

Curtis BM, O'Keefe JH Jr.

Postgrad Med. 2002 Aug;112(2):35-8, 41-5. Review.

PMID:
12198752
19.

How can the cardiac death rate be reduced in dialysis patients?

Curtis BM, Parfrey PS.

Semin Dial. 2002 Jan-Feb;15(1):22-4. No abstract available.

PMID:
11874586
20.

Autonomic tone as a cardiovascular risk factor: the dangers of chronic fight or flight.

Curtis BM, O'Keefe JH Jr.

Mayo Clin Proc. 2002 Jan;77(1):45-54. Review.

PMID:
11794458
22.

Enhanced hematopoietic activity of a human granulocyte/macrophage colony-stimulating factor-interleukin 3 fusion protein.

Curtis BM, Williams DE, Broxmeyer HE, Dunn J, Farrah T, Jeffery E, Clevenger W, deRoos P, Martin U, Friend D, et al.

Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5809-13.

23.

Experimental and theoretical studies of the three-dimensional structure of human interleukin-4.

Curtis BM, Presnell SR, Srinivasan S, Sassenfeld H, Klinke R, Jeffery E, Cosman D, March CJ, Cohen FE.

Proteins. 1991;11(2):111-9.

PMID:
1946344
24.

Expression cloning of a human granulocyte colony-stimulating factor receptor: a structural mosaic of hematopoietin receptor, immunoglobulin, and fibronectin domains.

Larsen A, Davis T, Curtis BM, Gimpel S, Sims JE, Cosman D, Park L, Sorensen E, March CJ, Smith CA.

J Exp Med. 1990 Dec 1;172(6):1559-70.

25.

IL-1 and its receptor are translocated to the nucleus.

Curtis BM, Widmer MB, deRoos P, Qwarnstrom EE.

J Immunol. 1990 Feb 15;144(4):1295-303.

PMID:
2137488
26.

T-cell interleukin 1 receptor cDNA expressed in Chinese hamster ovary cells regulates functional responses to interleukin 1.

Curtis BM, Gallis B, Overell RW, McMahan CJ, DeRoos P, Ireland R, Eisenman J, Dower SK, Sims JE.

Proc Natl Acad Sci U S A. 1989 May;86(9):3045-9.

27.

Expression of mRNA encoding voltage-dependent Ca channels in Xenopus oocytes. Review and progress report.

Lester HA, Snutch TP, Leonard JP, Nargeot J, Dascal N, Curtis BM, Davidson N.

Ann N Y Acad Sci. 1989;560:174-82. Review. No abstract available.

PMID:
2472764
29.

Molecular properties of voltage-sensitive calcium channels.

Catterall WA, Curtis BM.

Soc Gen Physiol Ser. 1987;41:201-13. No abstract available.

PMID:
2436311
30.
31.
32.
33.
34.

Solubilization of the calcium antagonist receptor from rat brain.

Curtis BM, Catterall WA.

J Biol Chem. 1983 Jun 25;258(12):7280-3.

35.

The mechanism of action of local anesthesia by tetraethylammonium derivatives.

Curtis BM, Scurlock JE.

Anesthesiology. 1981 Apr;54(4):270-7.

PMID:
6259968
36.

Tetraethylammonium derivatives: ultralong-acting local anesthetics?

Scurlock JE, Curtis BM.

Anesthesiology. 1981 Apr;54(4):265-9.

PMID:
6259967
37.

Dextran-local anesthetic interactions.

Scurlock JE, Curtis BM.

Anesth Analg. 1980 May;59(5):335-40. No abstract available.

PMID:
6154432
38.

Reactivation of neuritogenic activity of P2 protein from rabbit PNS myelin.

Curtis BM, Forno LS, Smith ME.

Brain Res. 1979 Oct 19;175(2):387-91. No abstract available.

PMID:
487166
39.

Frog sciatic nerve myelin: a chemical characterization.

Smith ME, Curtis BM.

J Neurochem. 1979 Aug;33(2):447-52. No abstract available.

PMID:
112219
40.

In vivo effect of LSD, morphine, ethanol and delta9-tetrahydrocannabinol on mouse brain adenosine triphosphatase activity.

Jain ML, Curtis BM, Bakutis EV.

Res Commun Chem Pathol Pharmacol. 1974 Jan;7(1):229-32. No abstract available.

PMID:
4272745

Supplemental Content

Loading ...
Support Center